We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidant Deal Signals Change in Device Investment Landscape
Guidant Deal Signals Change in Device Investment Landscape
February 3, 2006
Boston Scientific’s planned acquisition of Guidant foretells limits on the current strategy of incubating new technologies as start-ups and then selling them to large, established companies due to further industry consolidation, a venture capital firm says.